Virtu Financial’s NRX Pharmaceuticals Warrant NRXPW Stock Holding History

Virtu Financial’s Portfolio NRXPW Stock Details NRXPW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-13,967	Closed	-$1K	–	1863
2025 Q1	$1K	Sell	13,967 -11,549	-45%	-$2.02K	﹤0.01%	1270
2024 Q4	$4K	Sell	25,516 -9,172	-26%	-$570	﹤0.01%	1438
2024 Q3	$2K	Sell	34,688 -6,595	-16%	-$486	﹤0.01%	1270
2024 Q2	$2K	Buy	+41,283	New	+$5.18K	﹤0.01%	1209

Other funds holding NRXPW

Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Virtu Financial's NRXPW Position: Q2 2025 in Review

Virtu Financial sold out of NRX Pharmaceuticals Warrant (NRXPW) in Q2 2025, closing a stake of 13,967 shares — an estimated $1K sold.

Virtu Financial first reported a position in NRXPW in Q2 2024 and held it in 4 quarters. The position peaked at $4K in Q4 2024. 3 funds tracked by Wall St. Rank hold NRXPW as of Q2 2025.

Virtu Financial reported no remaining NRX Pharmaceuticals Warrant position as of Q2 2025 after selling out during the quarter.
Virtu Financial sold 13,967 NRX Pharmaceuticals Warrant shares in Q2 2025, an estimated $1K.
Virtu Financial first reported a position in NRX Pharmaceuticals Warrant in Q2 2024 and held it in 4 quarters.
Virtu Financial's NRX Pharmaceuticals Warrant position peaked at $4K in Q4 2024.
3 funds tracked by Wall St. Rank held NRX Pharmaceuticals Warrant as of Q2 2025.

Based on Virtu Financial's 13F filing for Q2 2025, filed 12 Aug 2025.